WAVERLEY PHARMA INC.

4-1250 Waverley Street

Winnipeg, Manitoba R3T 6C6

NOTICE OF ANNUAL AND SPECIAL MEETING OF SHAREHOLDERS

NOTICE is hereby given that the annual and special meeting (the "Meeting") of the shareholders of Waverley Pharma Inc. (the "Corporation") will be held in Winnipeg, Manitoba, at 4-1250 Waverley Street, on Thursday, June 20, 2024 at 11:00 a.m. (Central Daylight time) for the following purposes:

  1. to receive and consider the audited financial statements of the Corporation for the period ended December 31, 2023 together with the auditors' report thereon;
  2. to elect four (4) directors for the ensuing year, namely Dr. Albert D. Friesen, P. Marcus Enns, Larry Thiessen and James Kinley;
  3. to appoint auditors for the ensuing year and to authorize the directors to fix the remuneration to be paid to the auditors;
  4. to re-approve the Corporation's 10% rolling Stock Option Plan; and
  5. to transact such further or other business as may properly come before the Meeting or any adjournment thereof.

Shareholders unable to attend the Meeting in person are requested to read the enclosed Management Proxy Circular and Proxy, and then complete and deposit the Proxy together with the power of attorney or other authority, if any, under which it was signed or a notarially certified copy thereof with the Corporation's transfer agent, Computershare Trust Company of Canada, of 100 University Avenue, Toronto, Ontario, M5J 2Y1 at least 48 hours (excluding Saturdays, Sundays and statutory holidays) before the time of the Meeting. Unregistered shareholders who received the Proxy through an intermediary must deliver the Proxy in accordance with the instructions given by such intermediary.

NOTES:

  1. Holders of common shares of the Corporation are requested to sign and return, in the envelope provided for that purpose, the accompanying Proxy for use at the Meeting.
  2. Only holders of common shares of the Corporation of record at the close of business on May 2, 2024 will be entitled to vote at the Meeting.

DATED at Winnipeg, Manitoba, this 2nd day of May, 2024.

BY ORDER OF THE BOARD OF DIRECTORS

(Signed) "Albert D. Friesen"

Dr. Albert D. Friesen

Chairman

Attachments

Disclaimer

Waverley Pharma Inc. published this content on 23 May 2024 and is solely responsible for the information contained therein. Distributed by Public, unedited and unaltered, on 23 May 2024 18:27:04 UTC.